Identification and treatment of viral hepatitis C in persons who use drugs: a prospective, multicenter outreach study in Flanders, Belgium ...

Abstract Background Targeted screening for hepatitis C viral (HCV) infection is not yet widely executed in Belgium. When performed in people who use drugs (PWUD), it is mainly focused on those receiving opiate agonist therapy (OAT). We wanted to reach out to a population of difficult to reach PWUD not on centralized OAT, using non-invasive screening as a bridge to re-integration in medical care supported by facilitated referral to a specialist. Methods This was a prospective, multicenter cohort study in PWUD not enrolled in a centralized OAT program in a community-based facility in Limburg or... Mehr ...

Verfasser: Busschots, Dana
Kremer, Cécile
Bielen, Rob
Koc, Özgür Muhammet
Heyens, Leen
Dercon, Eefje
Verrando, Rita
Windelinckx, Tessa
Maertens, Griet
Bourgeois, Stefan
Niel Hens
Matheï, Catharina
Robaeys, Geert
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Verlag/Hrsg.: figshare
Schlagwörter: Medicine / Pharmacology / Biotechnology / 39999 Chemical Sciences not elsewhere classified / FOS: Chemical sciences / Science Policy / 110309 Infectious Diseases / FOS: Health sciences
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-29470267
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dx.doi.org/10.6084/m9.figshare.c.5427542.v1

Abstract Background Targeted screening for hepatitis C viral (HCV) infection is not yet widely executed in Belgium. When performed in people who use drugs (PWUD), it is mainly focused on those receiving opiate agonist therapy (OAT). We wanted to reach out to a population of difficult to reach PWUD not on centralized OAT, using non-invasive screening as a bridge to re-integration in medical care supported by facilitated referral to a specialist. Methods This was a prospective, multicenter cohort study in PWUD not enrolled in a centralized OAT program in a community-based facility in Limburg or OAT program in a community-based facility in Antwerp, Belgium, from October 2018 until October 2019. Two study teams recruited participants using an outreach method at 18 different locations. Participants were tested for HCV antibodies (Ab) by finger prick, and risk factors were assessed through a face-to-face questionnaire. Univariate analyses were used to assess the association between HCV Ab and each risk factor ...